Hua Lu

Affiliations: 
University of Maryland, Baltimore County, Baltimore, MD, United States 
Google:
"Hua Lu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chang H, Li Z, Zhang W, et al. (2024) Transfer of cGAMP from neuron to microglia activates microglial type I interferon responses after subarachnoid hemorrhage. Cell Communication and Signaling : Ccs. 22: 3
Rao D, Lu H, Wang X, et al. (2023) Correction: Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer. Elife. 12
Yu Y, Liu X, Li T, et al. (2023) Optimization of the cavity length and pulse characterization based on germanene as a saturable absorber in an Er-doped fiber laser. Applied Optics. 62: 9156-9163
Lv YF, Zhang H, Cui Z, et al. (2023) Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2. Bmc Cancer. 23: 1220
Lee H, Jung JH, Ko HM, et al. (2023) RNA-binding motif protein 10 inactivates c-Myc by partnering with ribosomal proteins uL18 and uL5. Proceedings of the National Academy of Sciences of the United States of America. 120: e2308292120
Huang C, Zhao W, Hao Q, et al. (2023) CKAP4 and mutant p53 cooperatively abrogate cell cycle checkpoint to induce genotoxic resistance in ovarian cancer. Clinical and Translational Medicine. 13: e1476
Huang Y, Xiong C, Wang C, et al. (2023) p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. Cell Reports. 42: 113426
Rao D, Lu H, Wang X, et al. (2023) Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer. Elife. 12
Go E, Aeschlimann FA, Lu H, et al. (2023) Von Willebrand factor antigen as a marker of disease activity in childhood-onset antineutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford, England)
Sun J, Chen J, Sun Y, et al. (2023) On the origin of the low immunogenicity and biosafety of a neutral α-helical polypeptide as an alternative to polyethylene glycol. Bioactive Materials. 32: 333-343
See more...